⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AVXL News
Anavex Life Sciences
Anavex Joins ACCESS-AD, a Major Initiative Funded by the European Commission, Through the Clinical Evaluation of Blarcamesine as Part of a Precision Medicine Approach in Alzheimer’s Disease
globenewswire.com
AVXL
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces an Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Investors with Substantial Losses Contact the Firm
prnewswire.com
AVXL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
prnewswire.com
AVXL
Anavex Life Sciences Appoints Senior Vice President Global Head of Neurology
globenewswire.com
AVXL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
accessnewswire.com
AVXL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anavex Life Sciences Corp. – AVXL
globenewswire.com
AVXL
Anavex Life Sciences Receives FDA Feedback on Alzheimer’s Disease Program
globenewswire.com
AVXL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
accessnewswire.com
AVXL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
accessnewswire.com
AVXL
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL
accessnewswire.com
AVXL